正川股份: 第四届董事会第二十三次会议决议公告

Group 1 - The board of directors of Chongqing Zhengchuan Pharmaceutical Packaging Materials Co., Ltd. held a meeting on August 22, 2025, with all 9 directors present, confirming the legality and validity of the meeting procedures [1] - The company’s 2025 semi-annual report was approved, stating that the report accurately reflects the financial and operational status of the company for the first half of 2025 [2] - The board unanimously agreed to the proposal regarding the timely and accurate disclosure of the use of raised funds, confirming no violations in the use of these funds [2] Group 2 - The company decided to make provisions for asset impairment based on prudent principles, ensuring that the provisions accurately reflect the asset status in compliance with accounting standards [3] - A new action plan titled "Quality Improvement, Efficiency Enhancement, and Return to Shareholders" for 2025 was approved, aligning with national policies aimed at enhancing the quality of listed companies [3]